personalized therapy based on mesenchymal stem cell extract in alopecia.

clinical study of a personalized therapy based on mesenchymal stem cell extract in hair regeneration in patients with alopecia.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221105056398N1

Enrollment

Registered

2022-12-05

Start date

2023-01-10

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

androgenic alopecia. Androgenic alopecia

Interventions

Intervention 1: Intervention group: Patients who receive personalized MSCs extract. Intervention 2: Intervention group: patients who receive the non-personalized MSCs extract. Intervention 3: Control

Eligibility

Sex/Gender

All

Age

18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Previous diagnosis of Androgenic alopecia. those who aged 18-59 years old.

Exclusion criteria

Exclusion criteria: Medications or supplements intake that can affect hair growth. (including finasteride, or any other hormonal products) History of any surgical procedure on the scalp for the treatment of hair loss History of hyperthyroidism or hypothyroidism Current pregnancy or breastfeeding History of allergic reactions to topical medications

Design outcomes

Primary

Measure	Time frame
Number of hair in bald area. Timepoint: day 1, week 8th and week 16th;. Method of measurement: Phototrichogram (hair scanner).;Hair diameter and Hair thickness. Timepoint: day 1, week 8th and week 16th;. Method of measurement: Phototrichogram (hair scanner).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Soleymani

Faculty of Medical Sciences, Tarbiat Modares University

f.solimani@modares.ac.ir+98 21 8866 2821

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026